Expression of an Activated Mammalian Target of Rapamycin (mTOR) in Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs)

被引：0
|
作者：
Dhall, D. [1 ]
Bose, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
566
引用
收藏
页码：135A / 135A
页数：1
相关论文
共 50 条
  • [1] Expression of an Activated Mammalian Target of Rapamycin (mTOR) in Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs)
    Dhall, D.
    Bose, S.
    LABORATORY INVESTIGATION, 2011, 91 : 135A - 135A
  • [2] Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
    Takashi Shida
    Takashi Kishimoto
    Mitsuko Furuya
    Takashi Nikaido
    Keiji Koda
    Shigetsugu Takano
    Fumio Kimura
    Hiroaki Shimizu
    Hiroyuki Yoshidome
    Masayuki Ohtsuka
    Tohru Tanizawa
    Yukio Nakatani
    Masaru Miyazaki
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 889 - 893
  • [3] Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
    Shida, Takashi
    Kishimoto, Takashi
    Furuya, Mitsuko
    Nikaido, Takashi
    Koda, Keiji
    Takano, Shigetsugu
    Kimura, Fumio
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Ohtsuka, Masayuki
    Tanizawa, Tohru
    Nakatani, Yukio
    Miyazaki, Masaru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (05) : 889 - 893
  • [4] Surgery for Gastroenteropancreatic Neuroendocrine Tumors (GEPNETS)
    Boudreaux, J. Philip
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (01) : 163 - +
  • [5] Immunohistochemical Analyses of Mammalian Target of Rapamycin (mTOR) Expression in Pituitary Neuroendocrine Tumors (PitNETs): mTOR as a Therapeutic Target for Functional PitNETs
    Nakazato, Ichiro
    Shiomi, Takayuki
    Oyama, Kenichi
    Matsuno, Akira
    Inomoto, Chie
    Osamura, R. Yoshiyuki
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2023, 56 (06) : 121 - 126
  • [6] Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors
    Jaume Capdevila
    Ramón Salazar
    Irene Halperín
    Albert Abad
    James C. Yao
    Cancer and Metastasis Reviews, 2011, 30 : 27 - 34
  • [7] Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors
    Capdevila, Jaume
    Salazar, Ramon
    Halperin, Irene
    Abad, Albert
    Yao, James C.
    CANCER AND METASTASIS REVIEWS, 2011, 30 (01) : 27 - 34
  • [8] Mammalian target of rapamycin (MTOR) signaling activation patterns in neuroendocrine tumors of the lung
    Righi, Luisella
    Volante, Marco
    Tavaglione, Veronica
    Rosas, Rosj
    Filosso, Pierluigi
    Novello, Silvia
    Ardissone, Francesco
    Papotti, Mauro
    VIRCHOWS ARCHIV, 2008, 452 : S15 - S15
  • [9] mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumors
    Kasajima, Atsuko
    Pavel, Marianne
    Darb-Esfahani, Silvia
    Noske, Aurelia
    Stenzinger, Albrecht
    Sasano, Hironobu
    Dietel, Manfred
    Denkert, Carsten
    Rocken, Christoph
    Wiedenmann, Bertram
    Weichert, Wilko
    CANCER RESEARCH, 2010, 70
  • [10] Expression of Components of the mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumors
    Kasajima, A.
    Pavel, M.
    Darb-Esfahani, S.
    Stenzinger, A.
    Sasano, H.
    Dietel, M.
    Denkert, C.
    Roecken, C.
    Wiedenmann, B.
    Weichert, W.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 8 - 8
12345